These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20369936)

  • 21. A fractional optimal control problem with final observation governed by wave equation.
    İğret Araz S
    Chaos; 2019 Feb; 29(2):023115. PubMed ID: 30823736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simple control policy for achieving minimum jerk trajectories.
    Yazdani M; Gamble G; Henderson G; Hecht-Nielsen R
    Neural Netw; 2012 Mar; 27():74-80. PubMed ID: 22137550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Koopman Invariant Subspaces and Finite Linear Representations of Nonlinear Dynamical Systems for Control.
    Brunton SL; Brunton BW; Proctor JL; Kutz JN
    PLoS One; 2016; 11(2):e0150171. PubMed ID: 26919740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Energy-Efficient Patching Strategy for Wireless Sensor Networks.
    Li P; Yang LX; Yang X; Zhong X; Wen J; Xiong Q
    Sensors (Basel); 2019 Jan; 19(2):. PubMed ID: 30634722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal time control of fed-batch bioreactor with product inhibition.
    Bayen T; Mairet F
    Bioprocess Biosyst Eng; 2013 Oct; 36(10):1485-96. PubMed ID: 23404101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sufficient optimality conditions for a class of epidemic problems with control on the boundary.
    Miniak-GOrecka A; Nowakowski A
    Math Biosci Eng; 2017 Feb; 14(1):263-275. PubMed ID: 27879132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer immunotherapy, mathematical modeling and optimal control.
    Castiglione F; Piccoli B
    J Theor Biol; 2007 Aug; 247(4):723-32. PubMed ID: 17543345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy.
    Ledzewicz U; Schättler H
    Math Biosci; 2007 Apr; 206(2):320-42. PubMed ID: 16197967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Learning-Based Predictive Control for Discrete-Time Nonlinear Systems With Stochastic Disturbances.
    Xu X; Chen H; Lian C; Li D
    IEEE Trans Neural Netw Learn Syst; 2018 Dec; 29(12):6202-6213. PubMed ID: 29993751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune therapeutic strategies using optimal controls with L
    Bara O; Djouadi SM; Day JD; Lenhart S
    Math Biosci; 2017 Aug; 290():9-21. PubMed ID: 28576678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of the optimal therapeutic protocols in cancer immunotherapy.
    Cappuccio A; Castiglione F; Piccoli B
    Math Biosci; 2007 Sep; 209(1):1-13. PubMed ID: 17416392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal control on hybrid ode systems with application to a tick disease model.
    Ding W
    Math Biosci Eng; 2007 Oct; 4(4):633-59. PubMed ID: 17924716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Free terminal time optimal control problem of an HIV model based on a conjugate gradient method.
    Jang T; Kwon HD; Lee J
    Bull Math Biol; 2011 Oct; 73(10):2408-29. PubMed ID: 21271294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2.
    Yoshizawa H; Chang AE; Shu S
    J Immunol; 1991 Jul; 147(2):729-37. PubMed ID: 1830072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble γc receptor attenuates anti-tumor responses of CD8
    Kim G; Hwang H; Jo Y; Lee B; Lee YH; Kim CH; Hong C
    Int J Cancer; 2018 Sep; 143(5):1212-1223. PubMed ID: 29577276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A switching control law approach for cancer immunotherapy of an evolutionary tumor growth model.
    Doban AI; Lazar M
    Math Biosci; 2017 Feb; 284():40-50. PubMed ID: 27665680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational imaging systems: joint design and end-to-end optimality.
    Mirani T; Rajan D; Christensen MP; Douglas SC; Wood SL
    Appl Opt; 2008 Apr; 47(10):B86-103. PubMed ID: 18382554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 21 treatment in a murine model as a novel potential cytokine immunotherapy for colon cancer.
    Chen C; Liu X; Ren Y
    Adv Clin Exp Med; 2018 May; 27(5):583-589. PubMed ID: 29616746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New developments in the application of optimal control theory to therapeutic protocols.
    Bayón L; Otero JA; Suárez PM; Tasis C
    Math Biosci; 2016 Feb; 272():34-43. PubMed ID: 26655362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.